BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 33527763)

  • 21. LINE-1 hypomethylation is associated with poor outcomes in locoregionally advanced oropharyngeal cancer.
    Casarotto M; Lupato V; Giurato G; Guerrieri R; Sulfaro S; Salvati A; D'Angelo E; Furlan C; Menegaldo A; Baboci L; Montico B; Turturici I; Dolcetti R; Romeo S; Baggio V; Corrado S; Businello G; Guido M; Weisz A; Giacomarra V; Franchin G; Steffan A; Sigalotti L; Vaccher E; Boscolo-Rizzo P; Jerry P; Fanetti G; Fratta E
    Clin Epigenetics; 2022 Dec; 14(1):171. PubMed ID: 36503584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma.
    Kreinbrink PJ; Li J; Parajuli S; Wise-Draper TM; Choi DL; Tang AL; Takiar V
    Oral Oncol; 2021 May; 116():105245. PubMed ID: 33901866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of genetic variants in clinical outcome of a cohort of patients with oropharyngeal squamous cell carcinoma.
    de Carvalho AC; Perdomo S; Dos Santos W; Fernandes GC; de Jesus LM; Carvalho RS; Scapulatempo-Neto C; de Almeida GC; Sorroche BP; Arantes LMRB; Melendez ME; De Marchi P; Hayes N; Reis RM; Carvalho AL
    Sci Rep; 2020 Jun; 10(1):9970. PubMed ID: 32561788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma.
    Pattle SB; Utjesanovic N; Togo A; Wells L; Conn B; Monaghan H; Junor E; Johannessen I; Cuschieri K; Talbot S
    Genes Chromosomes Cancer; 2017 Mar; 56(3):185-198. PubMed ID: 27750372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raptor and rictor expression in patients with human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Kondo S; Hirakawa H; Ikegami T; Uehara T; Agena S; Uezato J; Kinjyo H; Kise N; Yamashita Y; Tanaka K; Hasegawa N; Kiyuna A; Maeda H; Suzuki M; Gahana A
    BMC Cancer; 2021 Jan; 21(1):87. PubMed ID: 33482765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes after primary intensity-modulated radiation therapy for oropharyngeal squamous cell carcinoma at a New Zealand regional cancer centre: Impact of p16 status.
    Maqsood S; Jameson MB; De Groot C; Hartopeanu C; Yasin NABHM; Thotathil Z
    Cancer Rep (Hoboken); 2018 Jun; 1(1):e1001. PubMed ID: 32729235
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA-Pk
    Weaver AN; Cooper TS; Wei S; Carroll WR; Rosenthal EL; Yang ES
    Head Neck; 2017 Feb; 39(2):206-214. PubMed ID: 27507640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse-phase protein array profiling of oropharyngeal cancer and significance of PIK3CA mutations in HPV-associated head and neck cancer.
    Sewell A; Brown B; Biktasova A; Mills GB; Lu Y; Tyson DR; Issaeva N; Yarbrough WG
    Clin Cancer Res; 2014 May; 20(9):2300-11. PubMed ID: 24599934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oropharyngeal HPV Detection Techniques in HPV-associated Head and Neck Cancer Patients.
    Eggersmann TK; Baumeister P; Kumbrink J; Mayr D; Schmoeckel E; Thaler CJ; Dannecker C; Jeschke U; Nagler T; Mahner S; Sharaf K; Gallwas JKS
    Anticancer Res; 2020 Apr; 40(4):2117-2123. PubMed ID: 32234904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts.
    Lilja-Fischer JK; Ulhøi BP; Alsner J; Stougaard M; Thomsen MS; Busk M; Lassen P; Steiniche T; Nielsen VE; Overgaard J
    Acta Oncol; 2019 Oct; 58(10):1489-1494. PubMed ID: 31510843
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
    Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
    Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic implications of human papillomavirus status for patients with non-oropharyngeal head and neck squamous cell carcinomas.
    Ko HC; Harari PM; Sacotte RM; Chen S; Wieland AM; Yu M; Baschnagel AM; Bruce JY; Kimple RJ; Witek ME
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2341-2350. PubMed ID: 28752235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytology and direct human papillomavirus testing on fine needle aspirates from cervical lymph node metastases of patients with oropharyngeal squamous cell carcinoma or occult primary.
    Rollo F; Dona' MG; Pellini R; Pichi B; Marandino F; Covello R; Benevolo M
    Cytopathology; 2018 Oct; 29(5):449-454. PubMed ID: 29873841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y; Higuchi T; Matsumoto S; Iguchi M; Murakami I; Hyodo M; Daibata M
    Cancer Sci; 2021 Oct; 112(10):4404-4417. PubMed ID: 34382311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
    van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
    Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of human papillomavirus on the tumor microenvironment in oropharyngeal squamous cell carcinoma.
    Liu X; Liu P; Chernock RD; Lang Kuhs KA; Lewis JS; Li H; Gay HA; Thorstad WL; Wang X
    Int J Cancer; 2022 Feb; 150(3):521-531. PubMed ID: 34655477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Value of Radiologic Extranodal Extension in Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
    Lee B; Choi YJ; Kim SO; Lee YS; Hong JY; Baek JH; Lee JH
    Korean J Radiol; 2019 Aug; 20(8):1266-1274. PubMed ID: 31339014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple imputation and clinico-serological models to predict human papillomavirus status in oropharyngeal carcinoma: An alternative when tissue is unavailable.
    Ren J; Xu W; Su J; Ren X; Cheng D; Chen Z; Bender N; Mirshams M; Habbous S; de Almeida JR; Perez-Ordonez B; Goldstein DP; Wang JR; Bratman SV; Huang SH; Jang R; Zhao Y; Waterboer T; Hung RJ; Liu G
    Int J Cancer; 2020 Apr; 146(8):2166-2174. PubMed ID: 31269236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.
    Yamamoto Y; Takemoto N; Michiba T; Seo Y; Isohashi F; Otani K; Suzuki M; Fujii T; Yoshii T; Mitani K; Yasui T; Cho H; Tomita Y; Morii E; Teshima T; Ogawa K; Inohara H
    Int J Clin Oncol; 2019 Jun; 24(6):640-648. PubMed ID: 30694402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Novel Functional Splice Variant of
    Guo T; Sakai A; Afsari B; Considine M; Danilova L; Favorov AV; Yegnasubramanian S; Kelley DZ; Flam E; Ha PK; Khan Z; Wheelan SJ; Gutkind JS; Fertig EJ; Gaykalova DA; Califano J
    Cancer Res; 2017 Oct; 77(19):5248-5258. PubMed ID: 28733453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.